600380: Joincare Pharmaceutical Group Industry Co.,Ltd. - Summary | Jitta

Joincare Pharmaceutical Group Industry Co.,Ltd.

CHN:600380

Price
CN¥10.93
Loss Chance
42.3%
6.64JITTA SCORE
18.44%Over Jitta Line
Jitta Ranking
39 / 487
406 / 5,259
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (53)
Recent Business Performance (63)
Financial Strength (94)
Return to Shareholders (38)
Competitive Advantage (32)
Jitta Signs
Operating MarginExpansion
Debt LevelLow Long Term Debt
Dividend PayoutIncreasing Every Year
Share RepurchaseEvery Year
SG&A to SalesDecreasing
Revenue and EarningRevenue decline from 2022-2025
Key Stats
Jitta Score
Jitta Line
6.64
18.44%
4.42
> 1,000%
4.24
> 1,000%
Pharmaceuticals
6.36
2.64%
5.47
25.22%
7.76
43.10%
COMPANY DESCRIPTION
Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products in China and internationally. The company offers chemical pharmaceuticals for respiratory, gastroenterology, assisted reproduction, psychiatry, and anti-infection; chemical APIs and intermediates for drugs for humans and veterinary drugs; and traditional Chinese medicine, including cold medicine anti-viral granules and anti-tumor medicine. It also provides diagnostic reagents and equipment, such as mycoplasma pneumoniae IgM antibody test and antinuclear antibody test kit; OTC products which includes Taitai and Jingxin oral liquid, Eagle’s American ginseng tea, and YikeTie; and biologics comprising tocilizumab and mouse nerve growth factor injection. The company was founded in 1992 and is headquartered in Shenzhen, China.